Ikarian Capital, LLC - AYALA PHARMACEUTICALS INC ownership

AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 14 filers reported holding AYALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of AYALA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$759,000
-73.1%
697,316
-1.6%
0.14%
-62.8%
Q1 2022$2,819,000
-50.5%
708,383
+5.8%
0.37%
-56.3%
Q4 2021$5,696,000
-6.8%
669,271
+24.2%
0.85%
+97.4%
Q3 2021$6,112,000538,9390.43%
Other shareholders
AYALA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 542,977$5,533,0001.38%
SILVERARC CAPITAL MANAGEMENT, LLC 23,364$238,0000.11%
Redmile Group, LLC 667,816$6,805,0000.10%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 31,962$326,0000.01%
Marshall Wace North America L.P. 49,266$502,0000.00%
WELLINGTON MANAGEMENT GROUP LLP 704,363$7,178,0000.00%
Chevy Chase Trust Holdings, LLC 15,000$153,0000.00%
Tower Research Capital LLC (TRC) 470$4,0000.00%
UBS Group AG 5,509$56,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AYALA PHARMACEUTICALS INC shareholders